1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Nucleobindins: new trials by email Literature Review of Nucleobindins trials Research Report on Nucleobindins
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment - Chronic Hepatitis B | Phase 1 | Terminated | Hoffmann-La Roche | 60 | 2023-04-28 | 2026-01-22 |
Hong Kong (1) · New Zealand (1) · South Korea (1) · Spain (1) · Taiwan (1) · Thailand (1) · United States (1)